Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Cornberg

Showing results (21-30 of 350) with videos related to

Pageof 35
Sort By:
Antiviral Therapy|May 2, 2022
The curing regimens of HCV: A SWOT analysisMarkus Cornberg, Michael P Manns
Annals of Hepatology|September 24, 2005
New approaches and therapeutic modalities for the treatment of patients with chronic hepatitis CMarkus Cornberg, Michael P Manns
Hepatology (Baltimore, Md.)|November 4, 2025
Commentary - AASLD Practice Guideline on treatment of chronic hepatitis B (2025 Update)Alexander J Thompson, Markus Cornberg
The Lancet. Infectious Diseases|March 19, 2013
Sofosbuvir: the final nail in the coffin for hepatitis C?Michael P Manns, Markus Cornberg
Journal of Hepatology|May 28, 2021
Protected or not protected, that is the question - First data on COVID-19 vaccine responses in patients with NAFLD and liver transplant recipientsMarkus Cornberg, Christiane S Eberhardt
Alimentary Pharmacology & Therapeutics|November 5, 2024
Editorial: Stopping NUCs-When to Restart NUCs for the Best Outcome?Melanie Urbanek-Quaing, Markus Cornberg
Hepatology (Baltimore, Md.)|April 1, 2025
Reply: Refining epigenetic insights in HBV-specific T-cell restorationYin-Han Chou, Markus Cornberg
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Hepatitis C: individualised medicine versus one pill fits allMarkus Cornberg, Michael P Manns
Antiviral Therapy|November 25, 2015
ImPortance of IP-10 in hepatitis BMarkus Cornberg, Steffen B Wiegand
Journal of Hepatology|November 5, 2023
Population-based screening works: Effect of integrating screening for hepatitis B and C into the general health check-up in GermanyDietrich Hüppe, Heiner Wedemeyer, Markus Cornberg
Pageof 35

Showing results (21-30 of 350) with videos related to

Sort By:
Pageof 35
Antiviral Therapy|May 2, 2022
The curing regimens of HCV: A SWOT analysisMarkus Cornberg, Michael P Manns
Annals of Hepatology|September 24, 2005
New approaches and therapeutic modalities for the treatment of patients with chronic hepatitis CMarkus Cornberg, Michael P Manns
Hepatology (Baltimore, Md.)|November 4, 2025
Commentary - AASLD Practice Guideline on treatment of chronic hepatitis B (2025 Update)Alexander J Thompson, Markus Cornberg
The Lancet. Infectious Diseases|March 19, 2013
Sofosbuvir: the final nail in the coffin for hepatitis C?Michael P Manns, Markus Cornberg
Journal of Hepatology|May 28, 2021
Protected or not protected, that is the question - First data on COVID-19 vaccine responses in patients with NAFLD and liver transplant recipientsMarkus Cornberg, Christiane S Eberhardt
Alimentary Pharmacology & Therapeutics|November 5, 2024
Editorial: Stopping NUCs-When to Restart NUCs for the Best Outcome?Melanie Urbanek-Quaing, Markus Cornberg
Hepatology (Baltimore, Md.)|April 1, 2025
Reply: Refining epigenetic insights in HBV-specific T-cell restorationYin-Han Chou, Markus Cornberg
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Hepatitis C: individualised medicine versus one pill fits allMarkus Cornberg, Michael P Manns
Antiviral Therapy|November 25, 2015
ImPortance of IP-10 in hepatitis BMarkus Cornberg, Steffen B Wiegand
Journal of Hepatology|November 5, 2023
Population-based screening works: Effect of integrating screening for hepatitis B and C into the general health check-up in GermanyDietrich Hüppe, Heiner Wedemeyer, Markus Cornberg
Pageof 35